ClinicalTrials.gg

Peritoneal Neoplasms clinical trials

The registry lists 249 studies for Peritoneal Neoplasms across more than 10 countries. 55 are recruiting or about to start. 113 of them are mainly about Peritoneal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Peritoneal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
122
Recruiting
49
Terminated
26
Status unknown
24
Active, not recruiting
15
Not yet recruiting
6

Phase

Phase 2
90
Phase 1
54
Phase 3
31
Phase 4
2
Early Phase 1
2

Where

United States
92
France
40
Belgium
31
Germany
26
Spain
22
Italy
18

What is being tested here

Drugs under test in Peritoneal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Alkylating agents 5 open · Antimitotic agents 3 open · Antimetabolites 3 open · Angiogenesis inhibitors 2 open · Tyrosine kinase inhibitors (TKIs) 6

Coming up

12studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 49 Peritoneal Neoplasms studies recruiting now, 35 (71%) set no upper age limit and 8 (16%) stop at 75 or younger. 3 (6%) take children under 18. 8 (16%) are for women only and 0 (0%) for men only; 2 (4%) take healthy volunteers.

Recruiting studies that take each age, of 49
AgeWomenMen
103 (6%)2 (4%)
1846 (94%)38 (78%)
3049 (100%)41 (84%)
4049 (100%)41 (84%)
5049 (100%)41 (84%)
6549 (100%)41 (84%)
7547 (96%)39 (80%)
8538 (78%)33 (67%)

Across all 249 studies, recruiting or not: 17% stop at 75 or younger and 3% at 65; 8% take children; 27% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Peritoneal Neoplasms studies take

Of 28 phase 2 interventional studies under Peritoneal Neoplasms, half reached primary completion within 62 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 170 mo39–105 · 27 studies——
Phase 262 mo28–96 · 28 studies——
Interventional, no phase30 mo19–80 · 34 studies——
Observational71 mo23–… · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 249. Browse all 249 → or search them.